Summary A series of adult testicular germ cell tumours consisting of eight seminomas, 14 non-seminomas (including two cell lines) and two combined tumours was analysed by comparative genomic hybridization and, in some cases, by interphase fluorescence in situ hybridization. The gain of 12p was identified in all cases and additional material from chromosomes 7 and 8 was found in over 70% of cases, in keeping with previous analyses. Other consistent regions of gain included 1 q24-q31 (50%), 2p16-pter (41%), 2q22-q32 (45%) and Xql 1-q21 (50%). The loss of 1p32-p36 (36%), 9q31-qter (36%), 1 1q14-qter (50%), 16p (36%) and 18p (45%) and the loss of material from chromosomes 4 and 5 (50% and 36% respectively) were also found in all histological subtypes. The loss of 1 p material was confirmed in four cases by interphase FISH analysis and shown, with one exception, not to involve the loss of the D1Z2 locus at 1 p36.3, which is commonly deleted in paediatric germ cell tumours. An association between gain of 6q21-q24 with cases resistant to chemotherapy (P < 0.01) was observed. In addition, loss of chromosome 19 and 22 material and gain of 5q14-q23, 6q21-q24 and 13q were found at a significantly lower frequency in seminoma than non-seminoma. These regions may contain genes involved in the divergent development of seminoma and non-seminoma.
Adult and adolescent testicular germ cell tumours (TGCT) are a heterogeneous group of neoplasms. There are two main entities based on distinct clinical and morphological features, namely seminoma (SE) and non-seminoma (NS). The latter may be composed of neoplastic embryonic (embryonal carcinoma, immature and mature teratoma) or extra-embryonic tissue (yolk sac tumour and choriocarcinoma). In some instances, NS may be found together with a seminomatous component, in which case they are termed combined tumours (CT) (Mostofi and Sobin, 1977) . Most adult TGCT are associated with carcinoma in situ (CIS), from which they are thought to be derived (Skakkebaek et al, 1987) .
Approximately 80% of TGCT are associated with an isochromosome 12p (Atkin and Baker, 1983; Rodriguez et al, 1992; van Echten et al, 1995) and in i(12p) negative cases over-representation of the short arm of chromosome 12 has been demonstrated (Atkin et al, 1993; Suijkerbuijk et al, 1993; Rodriguez et al, 1993) . Cytogenetic studies have not identified any other highly consistent chromosome rearrangements that are associated with this group of tumours, although gains and losses of particular chromosomes have been noted (Rodriguez et al, 1992; Mitelman, 1994; van Echten et al, 1995) . Cytogenetic and other studies have demonstrated strong genetic similarities between SE and NS. This has led to the suggestion of a pathogenetic model in which CIS may progress to SE, associated with chromosome numbers in the hypertriploid range, which may develop into NS tumours that are associated with loss of chromosome material and a hyperdiploid chromosome complement. NS could also arise directly from CIS (de Jong et al, 1990; Rodriguez et al, 1992; Damjanov, 1993) .
Allele loss studies have identified specific regions of the genome that show loss of heterozygosity (LOH) , although the extent and significance of the loss is not clear (Sandberg et al, 1995) . Allele loss in a proportion of cases predicted to be greater than by random loss could indicate significant events in tumorigenesis. LOH may be associated with deletion of the corresponding genomic region, for example in a study of in situ breast carcinoma, 70% of LOH corresponded to deletion of the region (Lu and Shipley, unpublished) . In contrast to molecular analysis of specific loci, comparative genomic hybridization (CGH) (Kallioniemi et al, 1992; du Manoir et al, 1993) screens the whole genome for copy number changes. The power of CGH for localizing tumour-supressor genes has recently been demonstrated by its use to localize a tumour-suppressor locus for Peutz-Jeghers syndrome (Hemminki et al, 1997) .
There is cytogenetic evidence for genomic amplification in more advanced tumours (Samaniego et al, 1990; Suijkerbuijk et al, 1994) . Recent studies, including CGH analysis, have identified amplification of the 12pll.2-pl2.1 region (Suijkerbuijk et al, 1994; Korn et al, 1996; Mostert et al, 1996) and genomic gains including Ip32-p36, 2p23-p26, 4q12-q13, various regions on 6p, 17q and chromosomes 19 and X (Korn et al, 1996; Mostert et al, 1996; Speicher et al, 1995) . CGH has identified consistent regions of loss including material from chromosomes 4, 5, 6, 13 and 18 (Korn et al, 1996; Mostert et al, 1996) . To study the copy number changes in the genome of different subtypes of TGCT further, and to define the genomic regions that may be significant in tumour progression, CGH has been used here to screen the genome of well *Present address: Vysis UK, Rosedale House, Rosedale Road, Richmond, Surrey TW9 2SZ, UK 305 
MATERIALS AND METHODS Tumour samples and cell lines
Clinical and histological data on the 20 TGCT studied are summarized in Table 1 . Tumours with a number less than 30 have been previously studied for microsatellite instability (Huddart et al, 1995) . Samples 33 (SE) and 9, 13, 26 and 47 (NS) were received after chemotherapy. Normal tissue was trimmed from samples and the tumour was divided. Part of it was snap-frozen for DNA and tumour imprint preparation, and the remainder processed for histopathological examination by standard procedures. In addition, GCT27 and GCT44, two cell lines derived from NS tumours, were included in the study (Pera et al, 1987) .
CGH and digital image analysis CGH, capture of digital images and their analysis was carried out as described previously (Shipley et al, 1996; Weber-Hall et al, 1996a,b 
RESULTS

CGH analysis
This study reports the CGH results from 20 TGCTs, detailed in Table 1 , and also two cell lines. In control CGH experiments using differentially labelled normal DNA, the mean fluorescence ratios did not exceed 1.0 ± 0.1 (Figure 1 respectively, of NS. For chromosome 19 this represents a significant difference using Fisher's exact probability test (P = 0.0015).
Similarly, gain of 5ql4-q23 and 6q21-q24 was found in 43% of NS but not in any SE (P = 0.04). 13q was lost in 50% of SE but gained in 36% NS and loss of chromosome 22 was apparent in NS whereas gain of this chromosome was found in SE (P = 0.045, n = 11 and P = 0.0048, n = 16 respectively). The samples that were received after chemotherapy had changes similar to the other cases with the exception that gain of 6q21-q24 was significantly associated with the resistant tumours compared with the remainder (four out of five samples compared with two out of 17, P = 0.00934).
Interphase FISH analysis
Interphase FISH was carried out on selected cases with specific centromere probes (Table 3 ). The centromere copy numbers in tumour cells showed heterogeneity and there was a variable amount of normal cell contamination (Table 4 ). The size of the centromere signals for chromosome 12 was variable and their copy numbers generally high. This was attributed to the presence of the i(12p) chromosome, although it is not possible to predict in individual cases whether the rearrangement producing this chromosome results in a larger or smaller centromeric signal than that found in the normal chromosome 12 (Mukherjee et al, 1991) . The results from the analysis of the copy number of the PACs from the lp32 and lp35 region in relation to the pericentromeric probe for chromosome 1 for cases 33, 44, 36 and 39 showed loss of the region, consistent with the CGH analysis. However, similar analysis for the D1Z2 locus demonstrated, with one exception (case 36), that the D1Z2 locus was not lost (Table 4 and Figure 3 ). The interphase results for case 47 indicated loss of the pericentromeric marker in addition to the lp markers, which was consistent with CGH analysis that showed loss of the whole chromosome.
DISCUSSION
Adult germ cell tumours are a heterogeneous group of neoplasms both clinically and histologically and can display variable degrees of cellular differentiation. This study has identified regions of the genome frequently gained and lost in a total of 22 samples derived from different subtypes of TGCT, including five cases resistant to Molecular cytogenetics of germ cell tumours 311 A B C Figure 3 Example of interphase FISH analysis of 1 p markers. The marker for the pericentromeric region of chromosome 1 (green) was co-hybridized to nuclei from case 33 in separate experiments with differentially labelled markers (red) for (A) a PAC clone localizing to 1 p35, (B) a PAC clone localizing to 1 p32, and (C) the D1Z2 locus at the subtelomeric region of 1p. A and B show six signals corresponding to the pericentromeric region of chromosome 1 (green) and only four signals for each of the PAC clones (red). This loss, encompassing the 1 p32-35 region, is consistent with the CGH analysis. However, equal numbers of signal for the pericentromeric and D1Z2 markers were found (C), which is interpreted as retention of this locus chemotherapy. This has been achieved using the approach of CGH, and also, in some cases, interphase FISH analysis. The CGH approach is limited in the copy number changes it can detect. Theoretically, a single copy number change in a triploid genome would alter the ratio by 0.33 in the absence of contamination by normal cells or a heterogeneous cell population. Approximately more than one-third contamination would mean that single copy changes would not be detected using the criteria set out in the Materials and methods. The percentage contamination in the cases examined ranged from 20% to 60% and heterogeneity was found in the copy number of markers in nuclei as noted in other interphase studies (Looijenga et al, 1993; Speicher et al, 1995) . The results are therefore considered to underestimate the frequency of low-level copy number changes. A similar conclusion was previously reported (Mostert et al, 1996) . CGH analysis is also limited in resolution to detecting deletions greater than ten megabases in size. However, despite these limitations, CGH has been used here to identify areas of copy number change that are consistent with previous cytogenetic studies and LOH analysis. Novel regions of consistent gain and loss have also been determined that may indicate the location of oncogenes and tumoursuppressor genes involved in the development of these tumours.
Strikingly similar copy number changes were found in both the SE and NS analysed, in keeping with their suggested common developmental pathway (de Jong et al, 1990; Rodriguez et al, 1992; Damjanov, 1993; Sandberg et al, 1995) . Regions, common to NS and SE, included loss of 'p32-36 (36%), 9q31-qter (36%), I lql4-qter (50%), 16 p(36%), 17p (23%) and l9p (45%) and loss of material from chromosomes 4 (50%) and 5 (36%). Gain of the regions lq24-q31 (50%), 2pl6-pter (41%), 2q22-q32 (45%), 12p (100%), Xqll-q21 (50%) and chromosomes 7 and 8 (> 70%)
were also found in all histological subtypes.
The most consistent CGH finding was additional 12p material, which is in keeping with the i(l2p) chromosome found in 80% of TGCT and the over-representation of 12p material determined in FISH studies of i(12p) negative cases (Atkin et al, 1993; Rodriguez et al, 1993; Suijkerbuijk et al, 1993) . Cases with additional copies of the 12pl 1.2-12.1 region have been previously reported, suggesting that a subgroup of TGCT amplifies this region (Suijkerbuijk et al, 1994; Korn et al, 1996; Mostert et al, 1996) . None of the current series showed over-representation of this region, although we have recently identified a single case from a paraffin-embedded sample (B Summersgill, data not shown).
Loss of material from lp was found in 36% of the cases studied, with the consistent region of loss determined as lp32-p36. Interphase FISH using markers from the lp32 and lp35 region substantiated the CGH analysis. This loss is consistent with cytogenetic reports of deletions in the short arm of chromosome 1 (Rodriguez et al, 1992; Mitelman, 1994; van Echten et al, 1995) . Variable amounts of loss have been revealed by allelotype analysis of various loci on lp (Wang et al, 1980; Parrington et al, 1987; Mathew et al, 1994) , including up to 45% LOH in one of these studies (Mathew et al, 1994) . These results contrast with a recent CGH study of TGCT, which determined gain rather than loss of Ip material (Korn et al, 1996) .
Loss of material at the subtelomeric region of lp has been found as a common region of loss in various categories of germ cell tumours from young children. Cytogenetic analysis of GCT of the endodermal sinus type suggested a common area of deletion at lp36 (Perlman et al, 1996) . Interphase analysis using the marker for the PITSLRE locus at lp36, a candidate tumour-suppressor gene for involvement in neuroblastoma, demonstrated loss of this locus in eight out of ten paediatric cases. Similarly, Stock et al (1994) demonstrated loss of the DIZ2 locus in four GCTs of children (two testicular embryonal carcinomas and two sacral yolk sac tumours). The present study shows that the D1Z2 locus is not commonly lost in the adult TGCT and larger regions of lp are lost than in the paediatric cases. This difference may be significant in the different clinical and biological characteristics of adult and childhood GCTs. function of this gene may be important in germ cell tumour pathogenesis . However, one cannot exclude the possibility that other genes might be significant. Loss of chromosome 5 was found in approximately one-third of cases and correlates with LOH reported at 5pl5.1-pl5.2, Sqll and 5q34-q35 (Murty et al, 1996) . Loss of chromosome 4 material, particularly 4p and 4q24-qter, was found in over half the cases and may be of significance. Similarly, specific loss of the 1 1q14-qter region was frequently found.
A number of common regions of gain were found as summarized in Table 2 . These included gain of the lp24-q31 region and the 2p13-pter region, including three cases with gain of 2p24-p25. Gain and amplification of this latter region has been noted and the NMYC gene suggested as a candidate (Kom et al, 1996) . Gain of chromosome X, with a common overlapping region of Xql l-q21, was found. Klinefelter's syndrome (47, XXY) patients show an increased incidence of GCT and the cytogenetics of extra gonadal GCT and TGCT show an excess number of chromosome X (Mitelman, 1994) . Taken together with our results, this suggests a role for the X chromosome, and possibly Xql I-q21 in particular, in the development of adult GCT.
In addition, some overlapping regions of copy number change were less frequent or not found in the seminoma compared with the non-seminoma. These included loss of 15q and chromosome 19 material and gain of 5ql4-q23 and 6q21-q24. Loss of 13q was associated with SE whereas gain was noted in the NS and conversely for chromosome 22, loss was found in NS compared with gain in SE (Table 2) . These results suggest regions that may contain genes involved in the divergent development of SE and NS. The reduced levels of expression of the RBI gene at 13q14 noted particularly in SE may reflect the chromosome dosage differences observed here (Strohmeyer et al, 1991) . The difference in copy number of chromosome 15 and 22 material between SE and NS is consistent with previous cytogenetic and interphase FISH studies (Castedo et al, 1989a,b; Looijenga et al, 1993) .
One SE and four NS were received after chemotherapy. The number and sites of copy number change in these did not appear to be significantly different from the other samples with the exception of gain of 6q21-q24, which warrants further investigation. Determining significant rearrangements in the genome of TGCT amidst the considerable genomic instability is a difficult task. In contrast to molecular analysis of specific regions of the genome, the present study provides a global view of the copy number changes, and their frequency, which complements previous cytogenetic studies and indicates genomic regions for further study.
